Pre-pulse inhibition ( English prepulse inhibition, PPI ) - a decrease in the body's motor response to a strong sharp stimulus (impulse, English pulse ), usually sound , in the presence of a weak preliminary stimulus (pre-pulse, English prepulse ). PPI is an indicator of sensorimotor gating , which reflects the ability of the central nervous system to filter sensory information .
Pharmacological agents, as well as the genetic characteristics of the body and genetic mutations, mental and neurological diseases, organic disorders of the nervous system and other factors change the ability to pre-pulse inhibition. The most studied decrease in pre-pulse inhibition in patients with schizophrenia . [1] Various methods for measuring PPI in animals and humans are used to study the central nervous system, study the mechanisms of diseases and the effects of therapeutic methods on the body, and search for new antipsychotic drugs.
Content
PPI Measurement Procedure
When using sound stimuli, the amplitude of the so-called “ acoustic startle response ” ( ASR ) is measured . Non-sonic stimuli and their combinations are sometimes used - in this case they speak of a sensory startle response (SSR ). A stimulus can be a flash of light, a light click on an over- nose ( English glabellar tap ), a breath of air. A combination of different types of stimuli is practiced, for example, sound pre-pulse and click, or light pre-pulse and sound pulse.
Measurement of PPI in rodents takes place in the so-called " startle chambers ", equipped with motion detectors. In humans, the reaction of the oculomotor muscles is usually measured. When using sound, possible hearing impairments are taken into account.
Various interpulse intervals are used - 30, 60, 120, 240 and 480 ms. The interval duration is calculated from the beginning of the pre-pulse to the beginning of the pulse. At intervals longer than 500 ms, the reverse reaction usually occurs - prepulse facilitation (PPF ). The typical pre-pulse duration is 20 ms, and the pulse duration is 40 ms. An acoustic test usually uses background white noise . The pre-pulse volume, as a rule, is set above the background by 3-12 decibels , while acoustic stimuli are also usually white noise.
Key PPI Features
- The amplitude of inhibition reaches 65% in healthy people.
- Maximum inhibition is usually observed at an inter-pulse interval of 120 ms. [2]
- The basic reaction of fright does not affect the strength of inhibition - this was first noted in experiments with rats, [3] then confirmed in experiments on mice. [four]
- The reverse reaction, pre-pulse amplification, usually accompanies the inter-pulse intervals lasting more than 500 ms. PPF is believed to some extent reflect the ability to maintain attention .
- In men, on average, pre-pulse inhibition is stronger, while in women, pre-pulse amplification is more pronounced. [five]
- PPI is more pronounced when using only one ear than when using both. [6] [7]
- Inhibition of the reaction occurs at the first signal even during the first test, therefore, for the emergence of the PPI reaction, training and conditioning are not required. However, the lack of the impact of training on the PPI response is challenged. [eight]
- It is believed that the brevity of the delay between signals does not allow the use of volitional control in the response.
- At the same time, it is possible to set the task to ignore some pre-pulses and respond to others. In one study, healthy subjects demonstrated enhanced responses of PPI and PPF at intervals of 120 ms and 2000 ms to stimuli of a given type, and weakened responses to stimuli that needed to be ignored. [9]
- The amplitude of the fright reaction increases with an increase in background noise , as well as with an elongation of the pre-pulse.
- With stable background noise, the fright response is stronger than with pulsating. [ten]
PPI violation
Studies of PPI disorders are conducted in humans and many other species. PPI deficiencies in schizophrenia are the most studied, although they are typical not only for this disease. They are also noted in panic disorder , (Ludewig, et al., 2005) schizotypal personality disorder , [11] obsessive-compulsive disorder, (Swerdlow et al., 1993), Huntington’s disease, [12] enuresis , attention deficit (Ornitz et al. 1992), and Tourette’s syndrome (Swerdlow et al. 1994; Castellanos et al. 1996). According to one study, people with temporal lobe epilepsy and psychosis have PPI deficiency, while deviations are not found in the form of the disease without psychosis. [13] Therefore, PPI deficiencies are associated not with a specific disease, but with disorders in certain neural connections.
PPI Deficiency in Schizophrenia
A decrease in PPI has been described in many schizophrenia studies. The first mention dates back to 1978 . [14] Abnormalities were also noted in healthy relatives of patients. [15] [16] One study showed that when focusing on a prepulse, patients did not experience PPI enhancement. [17] Dopamine , which plays a significant role in schizophrenia, regulates the sensorimotor filtering of information in rodents. [18] [19] These findings fit into hypothetical descriptions of the dopamine mechanisms of the disease, possibly being associated with processes of sensory overload and fragmentation of cognitive processes.
Antipsychotics have been shown to increase PPI in patients, while atypical antipsychotics show a greater effect. Sexual differences in response in patients do not differ from those in healthy people: in men, inhibition is stronger. Patients showed a specific PPI deficiency at an interval of 60 ms; even with therapy, this interval gives a reduced inhibition reaction. [20]
It was noted that smokers have higher PPIs than non-smokers, with the strongest inhibition recorded in most smokers. [20] [21] This finding is consistent with evidence of patients' addiction to cigarettes . About 70% of patients smoke, [22] and many smoke more than 30 cigarettes per day. [23] Perhaps this somehow improves the condition of patients. In some works, the association of schizophrenia with the CHRNA7 and CHRFAM7A genes encoding the nicotinic receptor subunits is noted, but in other works this correlation is not found. [24] [25] Contrary to expectations, mouse alpha receptor subunit alpha7 subunits have normal PPI. [26]
Animal PPI Models
Active studies of PPI in animals are ongoing to better understand and model schizophrenia. [27] The methods for generating schizophrenia-like PPI disorders, according to a review by Geyer et al., Fit into four models: [28]
- Disruption of PPI by dopamine receptor agonists. Used when searching for antipsychotics.
- Use of 5-HT2 Serotonin Receptor Agonists
- Use of NMDA Antagonists
- Intervention in the development process (raising an animal in isolation, deprivation of communication with the mother). Various drugs are tested on such animals, and increased inhibition is considered a sign of a possible antipsychotic effect.
Genes Associated with PPI
- FABP7 , a marker of radial glia - association with PPI in mice, association with schizophrenia in humans. [29]
- 5-HT2A encoding a serotonin receptor . [thirty]
- Point knockout of the NCDN gene in mice reduces PPI by 20%. [31]
Links
- Prepulse Inhibition Deficits Predict Functional Difficulties in Schizophrenia - Schizophrenia Research Forum. Review of publication. [1] Translation: Pre-pulse inhibition (PPI) and the level of functioning of patients with schizophrenia (inaccessible link) .
Notes
- ↑ 1 2 Swerdlow NR, Light GA, Cadenhead KS, Sprock J., Hsieh MH, Braff DL Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function (English) / / Arch. Gen. Psychiatry : journal. - 2006 .-- December ( vol. 63 , no. 12 ). - P. 1325-1335 . - DOI : 10.1001 / archpsyc.63.12.1325 . - PMID 17146007 . (inaccessible link)
- ↑ Graham FK (1975). The more or less startling effects of weak prestimulation. Psychophysiology 12: 238-248. PMID 1153628
- ↑ Swerdlow NR, Geyer MA, Braff DL. (2001) Neural circuitry of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001; 156: 194-215. https://dx.doi.org/10.1007/s002130100799 PMID 11549223
- ↑ Paylor R, Crawley JN. (1997) Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 1997; 132: 169-180. https://dx.doi.org/10.1007/s002130050333 PMID 9266614
- ↑ Aasen I, Kolli L, Kumari V. Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J Psychopharmacol. 2005 Jan; 19 (1): 39-45. PMID 15671127
- ↑ Hoffman HS, Stitt CL. Inhibition of the glabella reflex by monaural and binaural stimulation. J Exp Psychol Hum Percept Perform. 1980 Nov; 6 (4): 769-76. PMID 6449543
- ↑ Kumari V, Fannon D, Sumich AL, Sharma T. (2007) Startle gating in antipsychotic-naive first episode schizophrenia patients: One ear is better than two. Psychiatry Res. 2007 Mar 21; [Epub ahead of print] PMID 17382404
- ↑ Amsterdam; New York: Elsevier, 2001 Attraction, Distraction and Action: multiple perspectives on attentional capture ; By Charles L. Folk, Bradley S. Gibson. ISBN 0-444-50676-4 Google books
- ↑ Filion DL, Dawson ME, Schell AM. (1993) Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biol Psychol. 1993 Jul; 35 (3): 185-200. PMID 8218613
- ↑ Hoffman, H., Fleshler, M. (1963, September 6). Startle reaction: Modificationby background acoustic stimulation. Science, 141, 928-930. PMID 14043340
- ↑ Cadenhead KS, Geyer MA, Braff DL. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 1993 Dec; 150 (12): 1862-7 PMID 8238643
- ↑ Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's Disease. J Neurol Neurosur Psychiatry 1995; 58: 192-200. PMID 7876851
- ↑ Morton, N., Gray, NS, Mellers, J., Toone, B., Lishman, WA, & Gray, JA (1994). Prepulse inhibition in temporal lobe epilepsy. Schizophrenic Research, 15, 191.
- ↑ Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978 Jul; 15 (4): 339-43. PMID 693742
- ↑ Kumari V, Das M, Zachariah E, Ettinger U, Sharma T. Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 2005 Sep; 42 (5): 588-94. PMID 16176381
- ↑ Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000 Oct; 157 (10): 1660-8. Erratum in: Am J Psychiatry 2000 Nov; 157 (11): 1904. PMID 11007721
- ↑ Hazlett EA, Romero MJ, Haznedar MM, New AS, Goldstein KE, Newmark RE, Siever LJ, Buchsbaum MS. (2007) Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophrenia Research 2007 May 1; PMID 17478083
- ↑ Mansbach RS, Geyer MA, Braff DL. (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 1988; 94: 507-514. PMID 3131796
- ↑ Swerdlow NR, Keith VA, Braff DL, Geyer MA. (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 1991; 256: 530-536. PMID 1825226
- ↑ 1 2 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. (2006) Startle gating deficits in a large cohort of patients with schizophrenia. Arch Gen Psych. December, 2006; 63: 1325-1335. PMID 17146007
- ↑ Kumari V, Soni W, Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol. 2001 Jun; 16 (4): 321-326. PMID 12404567
- ↑ Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, Gault J, Lee MJ, Logel J, Olincy A, Ross RG, Stevens K, Sullivan B, Vianzon R, Virnich DE, Waldo M, Walton K, Freedman R. Smoking and mental illness. Pharmacol Biochem Behav 2001; 70: 561-70
- ↑ De Leon J, Tracy J, McCann E, Mcgrory A, Diaz F. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophrenia Research 2002; 56: 55-65
- ↑ Gene Overview of All Published Schizophrenia-Association Studies for CHRFAM7A Archived September 27, 2007. - Schizophrenia Gene Database.
- ↑ Gene Overview of All Published Schizophrenia-Association Studies for CHRNA7 Archived September 27, 2007. - Schizophrenia Gene Database
- ↑ Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of alpha7-deficient mice. Learn Mem 1998; 5: 302-316
- ↑ Swerdlow NR, Geyer MA. (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998; 24: 285-301 PMID 9613626 free fulltext
- ↑ Geyer, MA, Krebs-Thomson, K, Braff, DL, Swerdlow, NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001; 156: 117-154. PMID 11549216
- ↑ Watanabe A., Toyota T., Owada Y., et al . Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype (eng.) // PLoS Biol. : journal. - 2007 .-- November ( vol. 5 , no. 11 ). - P. e297 . - DOI : 10.1371 / journal.pbio.0050297 . - PMID 18001149 .
- ↑ Maier W., Mössner R., Quednow BB, Wagner M., Hurlemann R. From genes to psychoses and back: the role of the 5HT2alpha receptor and prepulse inhibition in schizophrenia (Eng.) // Eur Arch Psychiatry Clin Neurosci : journal. - 2008 .-- November ( vol. 258 Suppl 5 ). - P. 40-3 . - DOI : 10.1007 / s00406-008-5011-5 . - PMID 18985293 .
- ↑ Scientific publication in the journal Science and a review on the thematic portal:
- Wang H., Westin L., Nong Y., Birnbaum S., Bendor J., Brismar H., Nestler E., Aperia A., Flajolet M., Greengard P. Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling (English) // [[Science (journal) | Science]]: journal. - 2009 .-- December ( vol. 326 , no. 5959 ). - P. 1554-1557 . - DOI : 10.1126 / science.1178496 . - PMID 20007903 .
- Meet Norbin — Behind the Scenes Player at mGluR5 Archived November 29, 2010. “Meet This Norbin - The Backstage Assistant of mGluR5 ” - Schizophrenia Research Forum , December 2009.